136 related articles for article (PubMed ID: 36911892)
21. Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
Zilli T; Benz E; Dipasquale G; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):318-322. PubMed ID: 27475672
[TBL] [Abstract][Full Text] [Related]
22. PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Zerini D; Jereczek-Fossa BA; Ciabattoni A; Mirri A; Bertoni F; Fersino S; D'Agostino G; Lohr F; Mortellaro G; Triggiani L; Marvaso G; Pepa M; Cuccia F; Alongi F;
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2311-2317. PubMed ID: 32583236
[TBL] [Abstract][Full Text] [Related]
23. Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review.
Bray G; Bahadori A; Rama D
Prostate; 2023 May; 83(6):489-497. PubMed ID: 36717113
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
Delerue C; Pasquier D; Bogart E; Mirabel X; Laffarguette J; Lals S; Barthoulot M; Lartigau E; Liem X
Radiother Oncol; 2024 Jan; 190():110029. PubMed ID: 38007041
[TBL] [Abstract][Full Text] [Related]
25. Single-fraction prostate-specific membrane antigen positron emission tomography- and multiparametric magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer local recurrences.
Ehret F; Hofmann T; Fürweger C; Kufeld M; Staehler M; Muacevic A; Haidenberger A
BJU Int; 2023 Jan; 131(1):101-108. PubMed ID: 36114771
[TBL] [Abstract][Full Text] [Related]
26. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
[TBL] [Abstract][Full Text] [Related]
27. A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma.
Ozyigit G; Cengiz M; Yazici G; Yildiz F; Gurkaynak M; Zorlu F; Yildiz D; Hosal S; Gullu I; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e263-8. PubMed ID: 21514737
[TBL] [Abstract][Full Text] [Related]
28. Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG.
Pasquier D; Martinage G; Janoray G; Rojas DP; Zerini D; Goupy F; De Crevoisier R; Bogart E; Calais G; Toledano A; Chauveinc L; Scher N; Bondiau PY; Hannoun-Levi JM; Silva M; Meyer E; Nickers P; Lacornerie T; Jereczek-Fossa BA; Lartigau E
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):727-734. PubMed ID: 31344433
[TBL] [Abstract][Full Text] [Related]
29. Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate Cancer: The Single-Center Experience.
Miszczyk L; Stąpór-Fudzińska M; Miszczyk M; Maciejewski B; Tukiendorf A
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785496. PubMed ID: 29983098
[TBL] [Abstract][Full Text] [Related]
30. CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed.
Detti B; Bonomo P; Masi L; Doro R; Cipressi S; Iermano C; Bonucci I; Franceschini D; Di Brina L; Baki M; Simontacchi G; Meattini I; Carini M; Serni S; Nicita G; Livi L
World J Urol; 2016 Mar; 34(3):311-7. PubMed ID: 26062525
[TBL] [Abstract][Full Text] [Related]
31. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer.
Loi M; Di Cataldo V; Simontacchi G; Detti B; Bonomo P; Masi L; Desideri I; Greto D; Francolini G; Carfora V; Pezzulla D; Perna M; Carta GA; Livi L
Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):93-100. PubMed ID: 29208480
[TBL] [Abstract][Full Text] [Related]
32. Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.
Zerini D; Jereczek-Fossa BA; Fodor C; Bazzani F; Maucieri A; Ronchi S; Ferrario S; Colangione SP; Gerardi MA; Caputo M; Cecconi A; Gherardi F; Vavassori A; Comi S; Cambria R; Garibaldi C; Cattani F; De Cobelli O; Orecchia R
Br J Radiol; 2015 Aug; 88(1052):20150197. PubMed ID: 26055506
[TBL] [Abstract][Full Text] [Related]
33. Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience.
Ponti E; Ingrosso G; Carosi A; Di Murro L; Lancia A; Pietrasanta F; Santoni R
Clin Genitourin Cancer; 2015 Aug; 13(4):e279-e284. PubMed ID: 25604915
[TBL] [Abstract][Full Text] [Related]
34. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
[TBL] [Abstract][Full Text] [Related]
37. Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: retrospective feasibility study on six cases.
Vavassori A; Jereczek-Fossa BA; Beltramo G; De Cicco L; Fariselli L; Bianchi LC; Possanzini M; Bergantin A; DeCobelli O; Orecchia R
Tumori; 2010; 96(1):71-5. PubMed ID: 20437861
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer : An investigation of 117 pelvic lymph nodes.
Cozzi S; Botti A; Timon G; Blandino G; Najafi M; Manicone M; Bardoscia L; Ruggieri MP; Ciammella P; Iotti C
Strahlenther Onkol; 2022 Aug; 198(8):700-709. PubMed ID: 34757443
[TBL] [Abstract][Full Text] [Related]
39. Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer.
Cuccia F; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Corradini S; Ruggieri R; Alongi F
Strahlenther Onkol; 2020 Jul; 196(7):628-636. PubMed ID: 32399638
[TBL] [Abstract][Full Text] [Related]
40. OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S; Vaugier L; Pasquier D; Buthaud X; Magné N; Peiffert D; Sargos P; Crehange G; Pommier P; Loos G; Hasbini A; Latorzeff I; Silva M; Denis F; Lagrange JL; Morvan C; Campion L; Blanc-Lapierre A
Eur Urol; 2021 Oct; 80(4):405-414. PubMed ID: 34247896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
